Meeting NewsVideo

VIDEO: Iluvien can optimize DME treatment

HONOLULU — The PALADIN and USER studies found patients with diabetic macular edema who received an Iluvien implant (fluocinolone acetonide, Alimera Sciences) required less frequent anti-VEGF treatments, Victor Gonzalez, MD, said at the Association for Research in Vision and Ophthalmology meeting here.

HONOLULU — The PALADIN and USER studies found patients with diabetic macular edema who received an Iluvien implant (fluocinolone acetonide, Alimera Sciences) required less frequent anti-VEGF treatments, Victor Gonzalez, MD, said at the Association for Research in Vision and Ophthalmology meeting here.

    See more from Association for Research in Vision and Ophthalmology